Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

References for PMC Articles for PubMed (Select 21632071)

1.

Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action.

Wunderlich FT, Ströhle P, Könner AC, Gruber S, Tovar S, Brönneke HS, Juntti-Berggren L, Li LS, van Rooijen N, Libert C, Berggren PO, Brüning JC.

Cell Metab. 2010 Sep 8;12(3):237-49. doi: 10.1016/j.cmet.2010.06.011.

2.

Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance.

Matthews VB, Allen TL, Risis S, Chan MH, Henstridge DC, Watson N, Zaffino LA, Babb JR, Boon J, Meikle PJ, Jowett JB, Watt MJ, Jansson JO, Bruce CR, Febbraio MA.

Diabetologia. 2010 Nov;53(11):2431-41. doi: 10.1007/s00125-010-1865-y. Epub 2010 Aug 11.

PMID:
20697689
3.

Human IL6 enhances leptin action in mice.

Sadagurski M, Norquay L, Farhang J, D'Aquino K, Copps K, White MF.

Diabetologia. 2010 Mar;53(3):525-35. doi: 10.1007/s00125-009-1580-8. Epub 2009 Nov 10.

4.

Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes.

Samuel VT, Beddow SA, Iwasaki T, Zhang XM, Chu X, Still CD, Gerhard GS, Shulman GI.

Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12121-6. doi: 10.1073/pnas.0812547106. Epub 2009 Jul 8.

5.

Dual role of interleukin-6 in regulating insulin sensitivity in murine skeletal muscle.

Nieto-Vazquez I, Fernández-Veledo S, de Alvaro C, Lorenzo M.

Diabetes. 2008 Dec;57(12):3211-21. doi: 10.2337/db07-1062. Epub 2008 Sep 16.

6.

Interleukin-6 regulates pancreatic alpha-cell mass expansion.

Ellingsgaard H, Ehses JA, Hammar EB, Van Lommel L, Quintens R, Martens G, Kerr-Conte J, Pattou F, Berney T, Pipeleers D, Halban PA, Schuit FC, Donath MY.

Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13163-8. doi: 10.1073/pnas.0801059105. Epub 2008 Aug 21.

7.

Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1.

Rodgers JT, Puigserver P.

Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12861-6. Epub 2007 Jul 23.

8.

IL-6 increases muscle insulin sensitivity only at superphysiological levels.

Geiger PC, Hancock C, Wright DC, Han DH, Holloszy JO.

Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1842-6. Epub 2007 Feb 27.

9.

Amelioration of glucose tolerance by hepatic inhibition of nuclear factor kappaB in db/db mice.

Tamura Y, Ogihara T, Uchida T, Ikeda F, Kumashiro N, Nomiyama T, Sato F, Hirose T, Tanaka Y, Mochizuki H, Kawamori R, Watada H.

Diabetologia. 2007 Jan;50(1):131-41. Epub 2006 Nov 9.

PMID:
17093946
10.

Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase.

Carey AL, Steinberg GR, Macaulay SL, Thomas WG, Holmes AG, Ramm G, Prelovsek O, Hohnen-Behrens C, Watt MJ, James DE, Kemp BE, Pedersen BK, Febbraio MA.

Diabetes. 2006 Oct;55(10):2688-97.

11.

Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle.

Al-Khalili L, Bouzakri K, Glund S, Lönnqvist F, Koistinen HA, Krook A.

Mol Endocrinol. 2006 Dec;20(12):3364-75. Epub 2006 Aug 31.

PMID:
16945991
12.

Nutrient control of phosphorylation and translocation of Foxo1 in C57BL/6 and db/db mice.

Aoyama H, Daitoku H, Fukamizu A.

Int J Mol Med. 2006 Sep;18(3):433-9.

PMID:
16865227
13.

Combined interleukin-6 and interleukin-1 deficiency causes obesity in young mice.

Chida D, Osaka T, Hashimoto O, Iwakura Y.

Diabetes. 2006 Apr;55(4):971-7.

14.

Interleukin-6 depletion selectively improves hepatic insulin action in obesity.

Klover PJ, Clementi AH, Mooney RA.

Endocrinology. 2005 Aug;146(8):3417-27. Epub 2005 Apr 21.

PMID:
15845623
15.

Interleukin-6 acts as insulin sensitizer on glycogen synthesis in human skeletal muscle cells by phosphorylation of Ser473 of Akt.

Weigert C, Hennige AM, Brodbeck K, Häring HU, Schleicher ED.

Am J Physiol Endocrinol Metab. 2005 Aug;289(2):E251-7. Epub 2005 Mar 8.

16.

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.

Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE.

Nat Med. 2005 Feb;11(2):183-90. Epub 2005 Jan 30.

17.

Adipokines: inflammation and the pleiotropic role of white adipose tissue.

Trayhurn P, Wood IS.

Br J Nutr. 2004 Sep;92(3):347-55. Review.

PMID:
15469638
18.

Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice.

Lin J, Wu PH, Tarr PT, Lindenberg KS, St-Pierre J, Zhang CY, Mootha VK, Jäger S, Vianna CR, Reznick RM, Cui L, Manieri M, Donovan MX, Wu Z, Cooper MP, Fan MC, Rohas LM, Zavacki AM, Cinti S, Shulman GI, Lowell BB, Krainc D, Spiegelman BM.

Cell. 2004 Oct 1;119(1):121-35.

PMID:
15454086
19.

Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients.

Rieusset J, Bouzakri K, Chevillotte E, Ricard N, Jacquet D, Bastard JP, Laville M, Vidal H.

Diabetes. 2004 Sep;53(9):2232-41.

20.

Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse.

Ueki K, Kondo T, Tseng YH, Kahn CR.

Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10422-7. Epub 2004 Jul 6. Erratum in: Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13710.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk